If approved, this would become the first oral GLP-1 treatment specifically designed for obesity management, representing a major milestone in pharmaceutical innovation
However, there is little information about -tocopherol intake in the Mexican population, which may have different dietary patterns from the U.S
Search strategy and study selection We conducted a comprehensive systematic search across five electronic databases: PubMed, Embase, Web of Science, Scopus, and the Cochrane Library, as well as the Google Scholar search engine, from inception to September 30, 2025, to identify studies investigating the association between GLP-1 receptor agonists and AUD outcomes
they are pharmacy-prepared versions of the same active ingredients found in the FDA-approved branded products (Wegovy, Ozempic, Mounjaro, Zepbound)
For individuals who cannot tolerate the gastrointestinal side effects of GLP-1 agonists, or who are seeking a compound with minimal systemic hormonal activity, AOD-9604's safety record is one of its few genuine selling points
Subcutaneous injection The most common administration route for research applications
